napabucasin
Showing 1 - 9 of 9
ADME, Healthy Trial in Madison (napabucasin)
Completed
- ADME
- Healthy
- napabucasin
-
Madison, WisconsinCovance Clinical Research Unit
Apr 4, 2022
Drug-drug Interactions Trial in DeLand (napabucasin, cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate)
Completed
- Drug-drug Interactions
- napabucasin
- cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate
-
DeLand, FloridaAccel Research Sites
Apr 4, 2022
Oncology Trial in Worldwide (Napabucasin, Nab-paclitaxel, Gemcitabine)
Completed
- Oncology
- Napabucasin
- +8 more
-
Atlanta, Georgia
- +6 more
Apr 4, 2022
NSCLC Trial in United States (Napabucasin, Paclitaxel)
Terminated
- Carcinoma, Non-Small-Cell Lung
- Napabucasin
- Paclitaxel
-
Beverly Hills, California
- +4 more
Apr 4, 2022
Metastatic Colorectal Cancer Trial in Kashiwa (Napabucasin, Pembrolizumab)
Terminated
- Metastatic Colorectal Cancer
- Napabucasin
- Pembrolizumab
-
Kashiwa, Chiba, JapanNational Cancer Center Hospital East
Aug 30, 2021
Carcinoma, Pancreatic Ductal Trial in Worldwide (Napabucasin, Nab-paclitaxel, Gemcitabine)
Completed
- Carcinoma, Pancreatic Ductal
- Napabucasin
- +2 more
-
Birmingham, Alabama
- +266 more
Apr 4, 2022
Colorectal Cancer Trial in Worldwide (Napabucasin, Fluorouracil, Leucovorin)
Completed
- Colorectal Cancer
- Napabucasin
- +4 more
-
Birmingham, Alabama
- +210 more
Mar 30, 2022
Metastatic Pancreatic Cancer Trial in Nanjing (Napabucasin, Paclitaxel, Gemcitabine)
Unknown status
- Metastatic Pancreatic Cancer
- Napabucasin
- +3 more
-
Nanjing, Jiangsu, ChinaThe 81st Hospital of Chinese PLA
Jun 17, 2019
Previously Treated Metastatic Colorectal Cancer Trial in China (Napabucasin, Fluorouracil, Leucovorin)
Unknown status
- Previously Treated Metastatic Colorectal Cancer
- Napabucasin
- +3 more
-
Bengbu, Anhui, China
- +36 more
Jun 17, 2019